2022
Electronic Nicotine Delivery Systems: An Updated Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology
Herbst RS, Hatsukami D, Acton D, Giuliani M, Moushey A, Phillips J, Sherwood S, Toll BA, Viswanath K, Warren NJH, Warren GW, Alberg AJ. Electronic Nicotine Delivery Systems: An Updated Policy Statement From the American Association for Cancer Research and the American Society of Clinical Oncology. Journal Of Clinical Oncology 2022, 40: 4144-4155. PMID: 36287017, DOI: 10.1200/jco.22.01749.Peer-Reviewed Original ResearchConceptsElectronic nicotine delivery systemsTobacco useENDS useCombustible tobaccoLong-term health risksEvidence-based treatmentsSurgeon General's ReportPublic healthNicotine delivery systemsTobacco-related disparitiesCombustible tobacco useBlood pressureSmoking cessationTobacco cessationCancer incidenceSmoking relapseClinical OncologyEpidemiological studiesImmune systemPotential efficacyE-cigarettesBrain developmentCancer developmentTobacco productsLongitudinal studyElectronic Nicotine Delivery Systems: An Updated Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology
Herbst RS, Hatsukami D, Acton D, Giuliani M, Moushey A, Phillips J, Sherwood S, Toll BA, Viswanath K, Warren NJH, Warren GW, Alberg AJ. Electronic Nicotine Delivery Systems: An Updated Policy Statement from the American Association for Cancer Research and the American Society of Clinical Oncology. Clinical Cancer Research 2022, 28: of1-of10. PMID: 36287033, DOI: 10.1158/1078-0432.ccr-22-2429.Peer-Reviewed Original ResearchConceptsElectronic nicotine delivery systemsTobacco useENDS useCombustible tobaccoLong-term health risksEvidence-based treatmentsSurgeon General's ReportPublic healthNicotine delivery systemsTobacco-related disparitiesCombustible tobacco useBlood pressureSmoking cessationTobacco cessationCancer incidenceSmoking relapseClinical OncologyEpidemiological studiesImmune systemPotential efficacyE-cigarettesBrain developmentCancer developmentTobacco productsLongitudinal study
2013
Reducing Tobacco‐Related Cancer Incidence and Mortality: Summary of an Institute of Medicine Workshop
Balogh EP, Dresler C, Fleury ME, Gritz ER, Kean TJ, Myers ML, Nass SJ, Nevidjon B, Toll BA, Warren GW, Herbst RS. Reducing Tobacco‐Related Cancer Incidence and Mortality: Summary of an Institute of Medicine Workshop. The Oncologist 2013, 19: 21-31. PMID: 24304712, PMCID: PMC3903060, DOI: 10.1634/theoncologist.2013-0230.Peer-Reviewed Original Research